Company Announcements

Amendment of Share Buyback

Source: RNS
RNS Number : 9307D
Frasers Group PLC
07 March 2022

Date: 07 March 2022



FRASERS GROUP PLC ("Frasers Group " or "the Company")





The Company announces that it has instructed Liberum Capital Limited to amend the terms of its share buyback programme to purchase the Company's shares during the period which will end on the trading day prior to the Company's financial year end on 24 April 2022 (the " Programme").


As previously announced, the aggregate purchase price of all shares acquired from 13 December 2021 to the trading day prior to the Company's financial year end on 24 April 2022 will be no greater than £70,000,000 and the maximum number of shares that may be purchased will be 10,000,000 ordinary shares.


The purpose of the Programme is to reduce the share capital of the Company.


The Programme (as amended) will be conducted within certain pre-set parameters, and in accordance with the general authority to repurchase shares granted by the Company's shareholders at the 2021 annual general meeting and Chapter 12 of the Financial Conduct Authority Listing Rules. A buy-back of ordinary shares on any trading day may exceed the 25% of the average daily trading volume specified in the provisions of the Market Abuse Regulation 596/2014/EU dealing with buyback programmes. The shares repurchased by the Company will be held in treasury pending cancellation or re-issue.




Frasers Group plc

Tom Piper, Company Secretary




T. 0344 245 9200



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.